Medicines with the active ingredient ustekinumab (ATC: L04AC05)
By: AOK SAXONY - ANHALT📍 GermanyOpen
Key Information
| Reference | GB-385341-2026 |
|---|
| Deadline | May 31, 2028 12:00 AM |
|---|
| Competition Type | NCB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Germany |
|---|
| Address | City : Magdeburg
Postal code : 39106
Telephone : +49 3912878-45117
Country : Germany |
|---|
| Published | Jun 5, 2026 |
|---|
Description
<br/>The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for finished medicinal products with the active ingredient...
Full details are available after unlocking this tender.